Pricing Log in Create free account
Friday 6 November 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.

Revenue
+41.2%
EPS
−3.67%
Free cash flow
+79.0%

Quarter to September 2026, against a year earlier

160.47 5.58 −3.36%
Market cap
$16.2B
P/E
23.0×
Fwd P/E
20.6×
Dividend yield
—
F-score
7/9
Altman Z
7.80
Beneish M
−2.64
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Neurocrine Biosciences, Inc. (NBIX) Book value per share

Alert me on Book value per share

Neurocrine Biosciences, Inc.'s book value per share at the end of fiscal 2025 was 32.7×, up 26.8% from 25.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 38.2×. Over the past ten years it has ranged from 3.6× (fiscal 2016) to 32.7× (fiscal 2025) — the current reading is the highest in ten years. Neurocrine Biosciences, Inc. ranks 5th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 32.7× 26.75%
FY2024 25.8× 12.91%
FY2023 22.8× 28.15%
FY2022 17.8× 22.74%
FY2021 14.5× 20.07%
FY2020 12.1× 73.98%
FY2019 7.0× 30.45%
FY2018 5.3× 26.17%
FY2017 4.2× 16.34%
FY2016 3.6× (27.71%)

Quarterly newest first

Period Book value per share Change
Sep 2026 38.2× 4.39%
Jun 2026 36.6× 7.86%
Mar 2026 33.9× 3.70%
Dec 2025 32.7× 8.20%
43 more quarters

Against its own ten years

Low 3.6× High 32.7×
Ten-year median 12.1×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
UTHR United Therapeutics Corporation compare 147×
NBIX Neurocrine Biosciences, Inc. 38.2×
ELAN Elanco Animal Health Incorporated compare 13.2×
ALKS Alkermes plc compare 11.1×
KNSA Kiniksa Pharmaceuticals International, plc compare 9.1×
ZTS Zoetis Inc. compare 7.5×
RDY Dr. Reddy's Laboratories Ltd compare 4.9×
HLN Haleon PLC Sponsored ADR compare 0.0×
VTRS Viatris Inc. compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on NBIX